Loading clinical trials...
Loading clinical trials...
INT-SCART-001: A Phase I Study Evaluating the Safety of Stereotactic Central Ablative Radiation Therapy (SCART) for Bulky Metastatic or Recurrent Cancer.
Conditions
Interventions
SCART radiation therapy
Locations
4
United States
Innovative Cancer Institute
Miami, Florida, United States
Baptist health
Corbin, Kentucky, United States
University of Kentucky Morehead Cancer Treatment Center
Morehead, Kentucky, United States
Foshan Chancheng Hospital
Foshan, Guangdong, China
Start Date
June 5, 2021
Primary Completion Date
May 5, 2022
Completion Date
May 5, 2022
Last Updated
May 11, 2021
NCT00026884
NCT03093909
NCT05934331
NCT07072143
NCT03162627
NCT03224000
Lead Sponsor
Baptist Health, Louisville
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions